Alyeska Investment Group
HCAT icon

Alyeska Investment Group’s Health Catalyst HCAT Stock Holding History

Alyeska Investment Group’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-346,089
Closed -$986K – 649
2025
Q3 		$986K Hold
346,089
– – ﹤0.01% 541
2025
Q2 		$1.3M Sell
346,089
-3,105
-0.9% -$12.2K ﹤0.01% 494
2025
Q1 		$1.58M Sell
349,194
-1,670,186
-83% -$8.84M 0.01% 424
2024
Q4 		$14.3M Buy
2,019,380
+861,150
+74% +$6.86M 0.05% 296
2024
Q3 		$9.43M Buy
1,158,230
+173,670
+18% +$1.25M 0.05% 300
2024
Q2 		$6.29M Hold
984,560
– – 0.04% 312
2024
Q1 		$7.41M Buy
984,560
+100,000
+11% +$913K 0.05% 301
2023
Q4 		$8.19M Sell
884,560
-33,769
-4% -$276K 0.05% 277
2023
Q3 		$9.29M Buy
918,329
+20,315
+2% +$243K 0.06% 291
2023
Q2 		$11.2M Buy
898,014
+150,644
+20% +$1.79M 0.08% 255
2023
Q1 		$8.72M Buy
747,370
+20,404
+3% +$260K 0.08% 255
2022
Q4 		$7.73M Buy
726,966
+55,500
+8% +$536K 0.08% 226
2022
Q3 		$6.51M Buy
+671,466
New +$8.89M 0.08% 243
2021
Q4 		– Sell
-50,000
Closed -$2.5M – 663
2021
Q3 		$2.5M Buy
+50,000
New +$2.73M 0.03% 460
2020
Q3 		– Sell
-214,799
Closed -$6.27M – 521
2020
Q2 		$6.27M Sell
214,799
-151,058
-41% -$4.17M 0.1% 244
2020
Q1 		$9.57M Buy
365,857
+54,261
+17% +$1.66M 0.19% 133
2019
Q4 		$10.8M Buy
311,596
+215,547
+224% +$7.14M 0.14% 163
2019
Q3 		$3.04M Buy
+96,049
New +$3.78M 0.04% 265

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alyeska Investment Group's HCAT Position: Q4 2025 in Review

Alyeska Investment Group sold out of Health Catalyst (HCAT) in Q4 2025, closing a stake of 346,089 shares — an estimated $986K sold.

Alyeska Investment Group first reported a position in HCAT in Q3 2019 and held it in 18 quarters. The position peaked at $14.3M in Q4 2024. 136 funds tracked by Wall St. Rank hold HCAT as of Q4 2025.

  • Alyeska Investment Group reported no remaining Health Catalyst position as of Q4 2025 after selling out during the quarter.
  • Alyeska Investment Group sold 346,089 Health Catalyst shares in Q4 2025, an estimated $986K.
  • Alyeska Investment Group first reported a position in Health Catalyst in Q3 2019 and held it in 18 quarters.
  • Alyeska Investment Group's Health Catalyst position peaked at $14.3M in Q4 2024.
  • 136 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2025.

Based on Alyeska Investment Group's 13F filing for Q4 2025, filed 13 Feb 2026.